Procter & Gamble (NYSE:PG) Price Target Increased to $170.00 by Analysts at Barclays

Procter & Gamble (NYSE:PGGet Free Report) had its price objective hoisted by equities research analysts at Barclays from $168.00 to $170.00 in a report released on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price would indicate a potential upside of 4.56% from the company’s current price.

PG has been the topic of several other research reports. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and increased their target price for the stock from $160.00 to $175.00 in a report on Monday, March 11th. Royal Bank of Canada raised their price target on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft lowered their price target on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research report on Monday. Finally, The Goldman Sachs Group initiated coverage on Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective for the company. Seven research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $168.81.

View Our Latest Stock Report on PG

Procter & Gamble Stock Performance

Shares of PG stock opened at $162.58 on Tuesday. The company has a market capitalization of $383.71 billion, a P/E ratio of 26.57, a price-to-earnings-growth ratio of 3.23 and a beta of 0.44. Procter & Gamble has a 52 week low of $141.45 and a 52 week high of $163.14. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The company’s 50 day moving average price is $159.46 and its two-hundred day moving average price is $153.32.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The firm had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company’s revenue was up .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.37 EPS. On average, analysts expect that Procter & Gamble will post 6.54 earnings per share for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the completion of the sale, the chief executive officer now directly owns 973 shares in the company, valued at $151,788. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now directly owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Ma. Fatima Francisco sold 45,000 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $156.00, for a total transaction of $7,020,000.00. Following the completion of the transaction, the chief executive officer now owns 973 shares of the company’s stock, valued at $151,788. The disclosure for this sale can be found here. Insiders sold 100,865 shares of company stock valued at $16,029,280 in the last quarter. Company insiders own 0.17% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Advantage Trust Co acquired a new position in shares of Procter & Gamble during the 4th quarter worth $28,000. Wyrmwood Management LLC bought a new position in Procter & Gamble in the fourth quarter valued at about $29,000. Naples Money Management LLC acquired a new position in Procter & Gamble during the fourth quarter worth about $29,000. Transcendent Capital Group LLC bought a new position in shares of Procter & Gamble in the fourth quarter worth about $31,000. Finally, Criterion Capital Advisors LLC acquired a new stake in shares of Procter & Gamble in the 4th quarter valued at approximately $33,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.